UNSPSC 85445108: The diagnosis of antiparkinsonism drugs

In this classification, this covers the group of activities that yields a diagnosis of antiparkinsonism drugs. Antiparkinsonism drugs is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y46.7.

UNSPSC 85445108 Diagnosis of antiparkinsonism drugs, a Commodity code, shows a significant mismatch between its nominal scope and the actual work being solicited under it by state and local governments. The recent opportunities posted under this code do not involve antiparkinsonism pharmaceuticals or their diagnosis. Instead, the tagged solicitations cover diagnostic imaging systems (PACS implementation), special education contracted services (speech therapy, occupational therapy, audiology), and temporary health professional staffing across ancillary clinical categories including audiology, respiratory care, sterile processing, and therapy services. The code appears to have been applied incorrectly to health system and school district procurement activities that fall outside pharmaceutical diagnosis entirely.

The issuing bodies with recent activity under this code include a county hospital system (San Mateo Medical Center), an independent school district (Birdville ISD in Texas), and a regional county health system (Santa Clara Health System). Geographic spread includes California (San Mateo and Santa Clara counties) and Texas (Tarrant County). Representative recent opportunities include San Mateo Medical Center's RFP for enterprise-grade PACS implementation with a due date of October 21, 2026, requiring EPIC integration and support for 65,000 annual radiology studies; Birdville ISD's competitive sealed proposal for special education contracted services across 23 line items (audiologist, speech language therapist, occupational therapist, and related specialties) due October 21, 2026; and Santa Clara Health System's non-exclusive multiple-award RFQ establishing a qualified vendor pool for temporary health professional staffing across 13 ancillary clinical categories, with a due date of October 7, 2026. The code shows little relevant recent activity aligned with antiparkinsonism drug diagnosis and likely represents a tagging error rather than active procurement under its intended scope.